Amphastar Pharmaceuticals ( 
AMPH ) is currently at historical resistance after reaching a new high today at $34.42. It's now above the average analyst target ($28.50 as of 3/7/2022) and insiders have sold $2.2 million in the past 2 months. Earnings on March 10th. The float is near 37 million with a 5.5% short interest. It is at "risk" for a squeeze/breakout, but given how extended the play is, there could be a selloff post-earnings. Gap to fill below between $26.20-$26.49. Target 1 is the gap fill / 50 EMA (yellow line).
AMPH ) is currently at historical resistance after reaching a new high today at $34.42. It's now above the average analyst target ($28.50 as of 3/7/2022) and insiders have sold $2.2 million in the past 2 months. Earnings on March 10th. The float is near 37 million with a 5.5% short interest. It is at "risk" for a squeeze/breakout, but given how extended the play is, there could be a selloff post-earnings. Gap to fill below between $26.20-$26.49. Target 1 is the gap fill / 50 EMA (yellow line).Dagangan ditutup: hentian tercapai
Earnings beat. Breakout. Failed idea in the near-term. Congrats to the bulls!
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.